Biogened Balance Sheet Health

Financial Health criteria checks 4/6

Biogened has a total shareholder equity of PLN39.2M and total debt of PLN21.3M, which brings its debt-to-equity ratio to 54.3%. Its total assets and total liabilities are PLN88.6M and PLN49.4M respectively. Biogened's EBIT is PLN9.0M making its interest coverage ratio 4.2. It has cash and short-term investments of PLN5.2M.

Key information

54.3%

Debt to equity ratio

zł21.29m

Debt

Interest coverage ratio4.2x
Cashzł5.16m
Equityzł39.21m
Total liabilitieszł49.43m
Total assetszł88.64m

Recent financial health updates

Recent updates

Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding

May 23
Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding

Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden

May 09
Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden

Biogened's (WSE:BGD) Promising Earnings May Rest On Soft Foundations

Feb 21
Biogened's (WSE:BGD) Promising Earnings May Rest On Soft Foundations

Is Biogened (WSE:BGD) A Risky Investment?

Feb 01
Is Biogened (WSE:BGD) A Risky Investment?

Biogened S.A. (WSE:BGD) Looks Just Right With A 37% Price Jump

Feb 01
Biogened S.A. (WSE:BGD) Looks Just Right With A 37% Price Jump

We Think Biogened (WSE:BGD) Can Stay On Top Of Its Debt

Jun 30
We Think Biogened (WSE:BGD) Can Stay On Top Of Its Debt

Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Oct 08
Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Is Biogened (WSE:BGD) A Risky Investment?

Jun 29
Is Biogened (WSE:BGD) A Risky Investment?

Does Biogened (WSE:BGD) Have A Healthy Balance Sheet?

Mar 25
Does Biogened (WSE:BGD) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Biogened (WSE:BGD) Is Using Debt Reasonably Well

Dec 09
These 4 Measures Indicate That Biogened (WSE:BGD) Is Using Debt Reasonably Well

Biogened (WSE:BGD) Has A Somewhat Strained Balance Sheet

Jul 29
Biogened (WSE:BGD) Has A Somewhat Strained Balance Sheet

Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Apr 30
Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Is Biogened (WSE:BGD) A Risky Investment?

Jan 24
Is Biogened (WSE:BGD) A Risky Investment?

Financial Position Analysis

Short Term Liabilities: BGD's short term assets (PLN54.3M) exceed its short term liabilities (PLN32.9M).

Long Term Liabilities: BGD's short term assets (PLN54.3M) exceed its long term liabilities (PLN16.5M).


Debt to Equity History and Analysis

Debt Level: BGD's net debt to equity ratio (41.1%) is considered high.

Reducing Debt: BGD's debt to equity ratio has increased from 42.6% to 54.3% over the past 5 years.

Debt Coverage: BGD's debt is well covered by operating cash flow (55.8%).

Interest Coverage: BGD's interest payments on its debt are well covered by EBIT (4.2x coverage).


Balance Sheet


Discover healthy companies